Cargando…
Promoter considerations in the design of lentiviral vectors for use in treating lysosomal storage diseases
More than 50 lysosomal storage diseases (LSDs) are associated with lysosomal dysfunctions with the frequency of 1:5,000 live births. As a result of missing enzyme activity, the lysosome dysfunction accumulates undegraded or partially degraded molecules, affecting the entire body. Most of them are li...
Autores principales: | Rintz, Estera, Higuchi, Takashi, Kobayashi, Hiroshi, Galileo, Deni S., Wegrzyn, Grzegorz, Tomatsu, Shunji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688940/ https://www.ncbi.nlm.nih.gov/pubmed/34977274 http://dx.doi.org/10.1016/j.omtm.2021.11.007 |
Ejemplares similares
-
Ferroptosis and Its Modulation by Autophagy in Light of the Pathogenesis of Lysosomal Storage Diseases
por: Pierzynowska, Karolina, et al.
Publicado: (2021) -
Molecular Mechanism of Induction of Bone Growth by the C-Type Natriuretic Peptide
por: Rintz, Estera, et al.
Publicado: (2022) -
Transcriptomic Changes Related to Cellular Processes with Particular Emphasis on Cell Activation in Lysosomal Storage Diseases from the Group of Mucopolysaccharidoses
por: Rintz, Estera, et al.
Publicado: (2020) -
Actin Cytoskeleton Polymerization and Focal Adhesion as Important Factors in the Pathomechanism and Potential Targets of Mucopolysaccharidosis Treatment
por: Gaffke, Lidia, et al.
Publicado: (2023) -
Bone Growth Induction in Mucopolysaccharidosis IVA Mouse
por: Rintz, Estera, et al.
Publicado: (2023)